Stock News

Stock Update (NASDAQ:ARIA): ARIAD Pharmaceuticals, Inc. Announces Issuance of Key U.S. Patent on Brigatinib

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced the issuance of its first U.

Company Update (NYSE:BABA): Alibaba Group Holding Ltd Establishes Collaborative Relationships With BMW MINI and Jaguar Land Rover

Alibaba Group Holding Ltd (NYSE:BABA)’s automobile business unit today established collaborative relationships with BMW MINI and Jaguar Land Rover aimed at enhancing customers’ …

Company Update (NASDAQ:CAMP): CalAmp Corp. Reports Record Fiscal 2015 Fourth Quarter and Full Year Results

CalAmp Corp. (NASDAQ:CAMP), a leading provider of wireless products, services and solutions, today reported results for its fourth quarter and full year ended February 28, …

Stock Update (NASDAQ:GPRO): GoPro Inc to Present at Investor Conferences in May

GoPro Inc (NASDAQ:GPRO), enabler of some of today’s most engaging content, announced that it will present at the following investor conferences in May 2015: Baird’s …

Company Update (NASDAQ:ILMN): Illumina, Inc. Reports Strong Start to Fiscal Year 2015

Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the first quarter of fiscal year 2015.

Company Update (NYSE MKT:RNN): New Data Show Rexahn Pharmaceuticals Inc’s Supinoxin(TM) Decreases Migration of Human Triple Negative Breast Cancer Cells in Metastatic Cancer Model

Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, announced that it presented preclinical …

Stock Update (NASDAQ:PPHM): Preclinical Data Demonstrate Anti-Tumor Effects of Peregrine Pharmaceuticals’ (PS)-Targeting Antibodies in Melanoma and Breast Cancer

Peregrine Pharmaceuticals (NASDAQ:PPHM) announced the presentation of data from preclinical studies demonstrating the combination of phosphatidylserine (PS) blockade with anti-PD-1 or anti-CTLA-4 immune …

Stock Update (NASDAQ:ARIA): ARIAD Pharmaceuticals, Inc. Announces Results of Preclinical Studies on Brigatinib at the AACR Annual Meeting

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor (TKI), brigatinib (AP26113) at …

Stock Update (NASDAQ:PCLN): Booking.com Announces Support of New Commitments in Europe

Today Booking.com, an operating business of Priceline Group Inc (NASDAQ:PCLN) announced its support of recent decisions by the National Competition Authorities in France, Italy …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts